NASDAQ:GILD Gilead Sciences (GILD) Earnings Date, Estimates & Call Transcripts $74.94 -0.48 (-0.64%) (As of 09/29/2023 08:53 PM ET) Add Compare Share Share Today's Range$74.58▼$75.7550-Day Range$73.94▼$80.6752-Week Range$61.44▼$89.74Volume4.18 million shsAverage Volume5.73 million shsMarket Capitalization$93.38 billionP/E Ratio17.23Dividend Yield4.00%Price Target$90.05 EarningsProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainabilityProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryUpcoming Earnings DateOct. 26EstimatedActual EPS (Aug. 3) $1.34 Missed By -$0.30 Consensus EPS (Aug. 3) $1.64 Read Call TranscriptListen to Call Get Gilead Sciences Earnings AlertsEnter your email address below to receive the latest news and earnings results for GILD and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueGILD Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.GILD Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Gilead Sciences Analyst ForecastsQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20234$1.43$1.92$1.73 Q2 20235$1.48$1.81$1.61 Q3 20235$1.46$1.93$1.73 Q4 20235$1.41$1.92$1.72 FY 202319$5.78$7.58$6.78 Q1 20243$1.59$1.97$1.74 Q2 20243$1.75$1.98$1.85 Q3 20243$1.85$2.11$2.02 Q4 20243$1.84$1.88$1.86 FY 202412$7.03$7.94$7.46 Q1 20251$1.62$1.62$1.62 Q2 20251$1.80$1.80$1.80 GILD Earnings Date and InformationGilead Sciences last posted its earnings results on August 3rd, 2023. The biopharmaceutical company reported $1.34 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.64 by $0.30. The firm had revenue of $6.60 billion for the quarter, compared to analysts' expectations of $6.45 billion. Its revenue for the quarter was up 5.4% on a year-over-year basis. Gilead Sciences has generated $4.35 earnings per share over the last year ($4.35 diluted earnings per share) and currently has a price-to-earnings ratio of 17.2. Earnings for Gilead Sciences are expected to grow by 11.14% in the coming year, from $6.64 to $7.38 per share. Gilead Sciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, October 26th, 2023 based off prior year's report dates.Read More Gilead Sciences Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 10/26/2023Estimated)------- 8/3/2023Q2 2023$1.64$1.34($0.30)$1.85$6.45 billion$6.60 billion 4/27/2023Q1 2023$1.63$1.37($0.26)$1.94$6.33 billion$6.35 billion 2/2/2023Q4 2022$1.50$1.67+$0.17$2.04$6.63 billion$7.39 billion 10/27/2022Q3 2022$1.44$1.90+$0.46$2.38$6.12 billion$7.04 billion8/2/2022Q2 2022$1.51$1.58+$0.07$2.25$5.88 billion$6.26 billion4/28/2022Q1 2022$1.77$2.12+$0.35$4.22$6.28 billion$6.59 billion Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. 2/1/2022Q4 2021$1.53$0.69($0.84)$1.08$6.64 billion$7.24 billion 10/28/2021Q3 2021$1.72$2.65+$0.93$3.25$6.31 billion$7.42 billion 7/29/2021Q2 2021$1.76$1.87+$0.11$2.53$6.15 billion$6.22 billion 4/29/2021Q1 2021$2.06$2.08+$0.02$2.79$6.78 billion$6.42 billion 2/4/2021Q4 2020$2.15$2.19+$0.04$3.15$7.11 billion$7.42 billion 10/28/2020Q3 2020$1.90$2.11+$0.21$3.93$6.20 billion$6.58 billion Gilead Sciences Earnings - Frequently Asked Questions When is Gilead Sciences's earnings date? Gilead Sciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, October 26th, 2023 based off last year's report dates. Learn more on GILD's earnings history. Did Gilead Sciences beat their earnings estimates last quarter? In the previous quarter, Gilead Sciences (NASDAQ:GILD) missed the analysts' consensus estimate of $1.64 by $0.30 with a reported earnings per share (EPS) of $1.34. Learn more on analysts' earnings estimate vs. GILD's actual earnings. How can I listen to Gilead Sciences's earnings conference call? The conference call for Gilead Sciences's latest earnings report can be listened to online. Listen to Conference Call How can I read Gilead Sciences's conference call transcript? The conference call transcript for Gilead Sciences's latest earnings report can be read online. Read Transcript How much revenue does Gilead Sciences generate each year? Gilead Sciences (NASDAQ:GILD) has a recorded annual revenue of $27.28 billion. How much profit does Gilead Sciences generate each year? Gilead Sciences (NASDAQ:GILD) has a recorded net income of $4.59 billion. GILD has generated $4.35 earnings per share over the last four quarters. What is Gilead Sciences's price-to-earnings ratio? Gilead Sciences (NASDAQ:GILD) has a trailing price-to-earnings ratio of 17.23 and a forward price-to-earnings ratio of 11.29. The price/earnings-to-growth ratio is 0.8. What is Gilead Sciences's EPS forecast for next year? Gilead Sciences's earnings are expected to grow from $6.64 per share to $7.38 per share in the next year, which is a 11.14% increase. More Earnings Resources from MarketBeat Related Companies: AMGN Earnings Date SGEN Earnings Date BIIB Earnings Date MRNA Earnings Date ARGX Earnings Date BNTX Earnings Date VRTX Earnings Date REGN Earnings Date ISRG Earnings Date CI Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: CarMax Slides On Earnings Disappointment, Time To Celebrate?5 Oversold Semiconductor Stocks to Nibble On Ahead of Q3 EarningsDoes Ciena's Earnings Beat Signal New Networking Boom Ahead?The 5 Most Upgraded Stocks From Q2 Earnings Reporting SeasonNordstrom: 3 Reasons the Pre-Earnings Dip Is an OpportunityWhat Ross Stores Earnings Say About The Saver Shopping Economy3 Ways To Trade, Trade Desk Stock Post Earnings This page (NASDAQ:GILD) was last updated on 10/2/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Gilead Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.